View Older Stories View More Recent Stories
-
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
-
Wells Fargo Reiterates Equal Weight Rating on Doximity Inc (DOCS)
-
BTIG Upgrades Doximity Inc (DOCS) to Buy
-
Raymond James Comments on Application Software Names VEEV and DOCS
-
Doximity Inc (DOCS) PT Lowered to $50 at Goldman Sachs
-
Doximity Shareholder Alert: Long-Term DOCS Investors Encouraged to Contact Kehoe Law Firm, P.C. - Breach of Fiduciary Duties Investigation
-
Doximity Inc (DOCS) PT Lowered to $52 at Truist as 'FY26 Outlook Disappoints'
-
Doximity Inc (DOCS) PT Lowered to $65 at Raymond James
-
Doximity Inc (DOCS) PT Lowered to $50 at Evercore ISI, Removed from TAP Outperform List
-
After-hours movers: Applied Materials, Take-Two, CAVA Group, Doximity
-
Doximity, Inc. (DOCS) Tops Q4 EPS by 11c; offers guidance
-
Leerink expects strong Q4 from Doximity, cuts target on valuation reset
-
Doximity Inc (DOCS) PT Lowered to $78 at Leerink Partners
-
Doximity Inc (DOCS) PT Lowered to $58 at Truist Securities
-
BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'
-
Doximity, Inc. (DOCS) mentioned as short at Captain's Log
-
RBC Capital Luxury Datawatch Stock Picks
-
DOXIMITY SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Doximity, Inc. (DOCS) and Encourages Long-Term Investors to Contact the Firm
-
DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Continues to Investigate Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties - DOCS
-
DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties - DOCS
-
Doximity Inc (DOCS) PT Raised to $88 at Jefferies, 'we believe shares should continue to command a premium multiple'
-
Doximity Inc (DOCS) PT Raised to $65 at Mizuho
-
Piper Sandler Upgrades Doximity Inc (DOCS) to Overweight
-
KeyBanc Reiterates Overweight Rating on Doximity Inc (DOCS) Following 'Big Beat & Raise'
-
Doximity Inc (DOCS) PT Raised to $82 at Needham
-
Doximity Inc (DOCS) PT Raised to $71 at Canaccord Genuity
-
Leerink Partners Upgrades Doximity Inc (DOCS) to Outperform
-
Doximity, Inc. (DOCS) Tops Q3 EPS by 11c; offers guidance
-
Mizuho Starts Doximity Inc (DOCS) at Neutral
-
Doximity Inc (DOCS) PT Raised to $48 at JPMorgan
-
Goldman Sachs Starts Doximity Inc (DOCS) at Neutral
-
Doximity Inc (DOCS) PT Raised to $49 at Truist Securities
-
Morgan Stanley Upgrades Doximity Inc (DOCS) to Equalweight
-
Canaccord Genuity Downgrades Doximity Inc (DOCS) to Hold
-
Doximity Inc (DOCS) PT Raised to $65 at Needham
-
Doximity Inc (DOCS) PT Raised to $54 at BofA Securities
-
KeyBanc Upgrades Doximity Inc (DOCS) to Overweight
-
Doximity, Inc. (DOCS) Tops Q2 EPS by 4c; offers guidance
-
Barclays Upgrades Doximity Inc (DOCS) to Overweight, 'Sales Made Simple'
-
Doximity Inc (DOCS) PT Raised to $45 at BofA Securities
-
Doximity Inc (DOCS) PT Raised to $43 at Jefferies
-
Doximity Inc (DOCS) PT Raised to $40 at Canaccord Genuity
-
Doximity Inc (DOCS) PT Raised to $35 at Truist Securities
-
Doximity Inc (DOCS) PT Raised to $31 at Piper Sandler
-
Midday movers: Expedia, Lilly rise; Array, Elf Beauty fall
-
Needham Upgrades Doximity Inc (DOCS) to Buy
-
Doximity Inc (DOCS) PT Raised to $34 at Evercore ISI
-
Doximity, Inc. (DOCS) Tops Q1 EPS by 6c; offers guidance
-
Wells Fargo Downgrades Doximity Inc (DOCS) to Underweight

